We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · August 03, 2021

Thyroid Dysfunction Impact in Patients With Metastatic Melanoma Treated With Anti–PD-1 Antibodies

Melanoma research

 

Additional Info

Melanoma research
Prognostic Impact of Thyroid Dysfunctions on Progression-Free Survival in Patients With Metastatic Melanoma Treated With Anti-PD-1 Antibodies
Melanoma Res. 2021 Jun 01;31(3)208-217, A Frelau, E Jali, B Campillo-Gimenez, M Pracht, M Porneuf, M Dinulescu, J Edeline, L Boussemart, T Lesimple

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading